Scarica l'app Stockscreener
8.0312
0.32%
-0.0288
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVAX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$8.06
Aprire:
$8
Volume 24 ore:
563.59K
Relative Volume:
0.09
Capitalizzazione di mercato:
$1.28B
Reddito:
$793.74M
Utile/perdita netta:
$-398.71M
Rapporto P/E:
-1.1062
EPS:
-7.26
Flusso di cassa netto:
$-514.43M
1 W Prestazione:
+11.27%
1M Prestazione:
-20.77%
6M Prestazione:
-46.12%
1 anno Prestazione:
+50.17%
Intervallo 1D:
$7.955
$8.18
Intervallo di 1 settimana:
$6.81
$8.18
Portata 52W:
$3.5324
$23.86
Novavax Inc Stock (NVAX) Company Profile
Nome
Novavax Inc
Settore
Industria
Telefono
240-268-2000
Indirizzo
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Confronta NVAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| NVAX | 8.02 | 1.28B | 793.74M | -398.71M | -514.43M | -7.26 |
| VRTX | 446.52 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 741.51 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 592.50 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.90 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.19 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-08-09 | Aggiornamento | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Reiterato | B. Riley Securities | Buy |
| 2022-12-30 | Reiterato | H.C. Wainwright | Buy |
| 2022-12-02 | Iniziato | Jefferies | Hold |
| 2022-09-22 | Downgrade | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Iniziato | BofA Securities | Underperform |
| 2022-02-23 | Reiterato | B. Riley Securities | Buy |
| 2022-02-22 | Ripresa | Jefferies | Buy |
| 2022-01-21 | Iniziato | Cowen | Outperform |
| 2021-05-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Iniziato | Jefferies | Buy |
| 2020-08-06 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-05 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Downgrade | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-08 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Reiterato | B. Riley FBR | Buy |
| 2020-06-29 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-05 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Reiterato | B. Riley FBR | Buy |
| 2020-05-12 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-30 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-27 | Ripresa | B. Riley FBR | Buy |
| 2019-08-14 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-28 | Downgrade | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-12-11 | Iniziato | Oppenheimer | Outperform |
| 2018-11-26 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Aggiornamento | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Aggiornamento | Seaport Global Securities | Neutral → Buy |
Mostra tutto
Novavax Inc Borsa (NVAX) Ultime notizie
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Menopause Treatment Market Opportunities, Challenges, - openPR
What is B. Riley's Estimate for Novavax FY2024 Earnings? - MarketBeat
Novavax to Present at Jefferies London Conference - TipRanks
Preventive Vaccines Market May Set New Growth Story | Takeda - openPR
Health Care Flat After Last Week's SelloffHealth Care Roundup - Marketscreener.com
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
How To Trade (NVAX) - Stock Traders Daily
FY2024 Earnings Forecast for Novavax Issued By HC Wainwright - MarketBeat
Novavax Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Big Pharma Stocks Drop After RFK Jr. Announced as Health Secretary - Newsweek
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? - Yahoo! Voices
UK regulator approves adapted Novavax jab - The Pharma Letter
Health stocks slide as Trump picks vaccine skeptic Kennedy - Los Angeles Times
Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance
Vaccine maker stocks fall after conspiracy theory-spreading RFK Jr. tapped to lead health department - New York Post
Shot Down: Vaccine stocks tumble with RFK Jr. as Health SecretaryFinbold - Finbold - Finance in Bold
Robert F. Kennedy Jr.’s Billion-Dollar Hit to Big Pharma - The New York Times
Health Stocks Slide as Trump Picks Vaccine Skeptic Kennedy - Yahoo Finance
Novavax, Inc. (NASDAQ:NVAX) Just Reported, And Analysts Assigned A US$16.67 Price Target - Simply Wall St
Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary - Fast Company
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) - The Malaysian Reserve
Vaccine Stocks Fall After Trump Selects RFK Jr. to Lead HHS - Yahoo Finance
WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill - Benzinga
Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance
Novavax, Inc. (NASDAQ:NVAX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna, Novavax Stock Slide. - Barron's
Vaccine Maker Stocks Fall After Trump Taps RFK Jr. to Head HHS - MSN
Vaccine maker stocks tumble after Trump picks RFK Jr. for health secretary - CNN
Moderna, Novavax Shares Slip After Trump Names RFK Jr. Health Chief Nominee - Wall Street Pit
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Big Pharma stocks tumble as Trump nominates RFK Jr. to lead HHS - The National Desk
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower - Benzinga
Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut - MSN
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data - Yahoo Finance
Novavax to Participate in Jefferies London Healthcare Conference - StreetInsider.com
Novavax Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Novavax (NVAX) Stock Experiences Significant Drop Amid Industry Volatility - GuruFocus.com
Protein-based Vaccine Sales Strategy Advances - Precision Vaccinations
Novavax (NASDAQ:NVAX) Posts Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript - Insider Monkey
Stock Market Increases While Tesla And Novavax Take A Hit - Finimize
Novavax Q3 Earnings Disappoint, But A Turnaround May Be Underway (NASDAQ:NVAX) - Seeking Alpha
Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic P - GuruFocus.com
Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial ... - Yahoo Finance
Novavax Advances Vaccine Strategy Amid Financial Shifts - TipRanks
Earnings call: Novavax outlines strategic growth and partnership with Sanofi - Investing.com
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Novavax (NVAX) Reports Q3 Loss, Tops Revenue Estimates - MSN
Novavax Becomes Oversold (NVAX) - Nasdaq
Novavax Inc Azioni (NVAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Novavax Inc Azioni (NVAX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Trizzino John | EVP, CCO and CBO |
Aug 19 '24 |
Option Exercise |
0.00 |
655 |
0 |
28,627 |
| Kelly James Patrick | EVP, CFO and Treasurer |
Aug 16 '24 |
Option Exercise |
12.96 |
2,367 |
30,676 |
15,652 |
| YOUNG JAMES F | Director |
Jun 21 '24 |
Sale |
14.09 |
7,500 |
105,675 |
61,760 |
| YOUNG JAMES F | Director |
Jun 18 '24 |
Sale |
13.72 |
7,500 |
102,881 |
69,260 |
| Dubovsky Filip | President, R&D |
Jun 17 '24 |
Option Exercise |
6.18 |
13,904 |
85,911 |
80,517 |
| Dubovsky Filip | President, R&D |
Jun 17 '24 |
Sale |
14.47 |
13,904 |
201,164 |
66,613 |
| MCGLYNN MARGARET G | Director |
Jun 12 '24 |
Option Exercise |
0.00 |
6,670 |
0 |
10,470 |
| Alton Gregg H | Director |
Jun 12 '24 |
Option Exercise |
0.00 |
6,670 |
0 |
10,470 |
| DOUGLAS RICHARD | Director |
Jun 12 '24 |
Option Exercise |
0.00 |
6,670 |
0 |
43,920 |
| King Rachel K. | Director |
Jun 12 '24 |
Option Exercise |
0.00 |
6,670 |
0 |
18,920 |
0.42%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):